30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Christopher Reading

Insider profile

Currently holds a position at U.S. Physical Therapy Inc

Performance

Overall performance
2.7

Performance over holding periods
2.7
30 days 90 days 120 days
Average return 2% 8.2% 15.1%
Success rate 68% 68% 82%
Transactions
10 0% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
President, Chief Executive Officer, Director U.S. Physical Therapy Inc Nov. 1, 2004 -

Christopher Reading's trades of U.S. Physical Therapy Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2025-09-05 2025-09-04 S Sale
66,252 -28.1%
145.60
US$104,678
66,252 -28.1% 145.60 US$104,678
2025-09-04 2025-09-04 PrS Proposed sale
58,039
109.40
US$977,639
58,039 109.40 US$977,639
2024-05-31 2024-05-30 S Sale
40,804 +12.8%
184.07
US$2,599,188
40,804 +12.8% 184.07 US$2,599,188
2024-05-29 2024-05-29 S Sale
1,000 -1.0%
100.13
US$100,130
1,000 -1.0% 100.13 US$100,130
2024-05-29 2024-05-28 S Sale
1,100 -1.1%
102.13
US$112,343
1,100 -1.1% 102.13 US$112,343
2024-05-28 2024-05-28 PrS Proposed sale
5,000
102.18
US$510,900
5,000 102.18 US$510,900
2022-12-07 2022-12-05 S Sale
5,000 -6.3%
90.00
US$450,000
5,000 -6.3% 90.00 US$450,000
2022-12-05 2022-12-02 S Sale
10,000 -11.2%
90.01
US$900,100
10,000 -11.2% 90.01 US$900,100
2021-12-20 2021-12-17 S Sale
12,000 -14.7%
93.89
US$1,126,680
12,000 -14.7% 93.89 US$1,126,680
2020-12-04 2020-12-04 S Sale
6,000 -7.8%
106.67
US$640,020
6,000 -7.8% 106.67 US$640,020
2019-05-22 2019-05-21 S Sale
9,860 -12.5%
120.52
US$1,188,327
9,860 -12.5% 120.52 US$1,188,327
2019-05-22 2019-05-20 S Sale
10,000 -11.2%
118.22
US$1,182,200
10,000 -11.2% 118.22 US$1,182,200